Vis enkel innførsel

dc.contributor.authorBen-Elazar, Shay
dc.contributor.authorAure, Miriam Ragle
dc.contributor.authorJonsdottir, Kristin
dc.contributor.authorLeivonen, Suvi-Katri
dc.contributor.authorKristensen, Vessela N.
dc.contributor.authorJanssen, Emiel
dc.contributor.authorSahlberg, Kristine Kleivi
dc.contributor.authorLingjærde, Ole Christian
dc.contributor.authorYakhini, Zohar
dc.date.accessioned2021-06-24T09:36:37Z
dc.date.available2021-06-24T09:36:37Z
dc.date.created2021-06-21T16:59:33Z
dc.date.issued2021-02
dc.identifier.citationBen-Elazar, S., Aure, M.R., Jonsdottir, K. et al. (2021) miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer. PLoS Computational Biology, 17 (2).en_US
dc.identifier.issn1553-734X
dc.identifier.urihttps://hdl.handle.net/11250/2761075
dc.description.abstractDifferent miRNA profiling protocols and technologies introduce differences in the resulting quantitative expression profiles. These include differences in the presence (and measurability) of certain miRNAs. We present and examine a method based on quantile normalization, Adjusted Quantile Normalization (AQuN), to combine miRNA expression data from multiple studies in breast cancer into a single joint dataset for integrative analysis. By pooling multiple datasets, we obtain increased statistical power, surfacing patterns that do not emerge as statistically significant when separately analyzing these datasets. To merge several datasets, as we do here, one needs to overcome both technical and batch differences between these datasets. We compare several approaches for merging and jointly analyzing miRNA datasets. We investigate the statistical confidence for known results and highlight potential new findings that resulted from the joint analysis using AQuN. In particular, we detect several miRNAs to be differentially expressed in estrogen receptor (ER) positive versus ER negative samples. In addition, we identify new potential biomarkers and therapeutic targets for both clinical groups. As a specific example, using the AQuN-derived dataset we detect hsa-miR-193b-5p to have a statistically significant over-expression in the ER positive group, a phenomenon that was not previously reported. Furthermore, as demonstrated by functional assays in breast cancer cell lines, overexpression of hsa-miR-193b-5p in breast cancer cell lines resulted in decreased cell viability in addition to inducing apoptosis. Together, these observations suggest a novel functional role for this miRNA in breast cancer. Packages implementing AQuN are provided for Python and Matlab: https://github.com/YakhiniGroup/PyAQN.en_US
dc.language.isoengen_US
dc.publisherPublic Library of Science (PLoS)en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectbrystkreften_US
dc.titlemiRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast canceren_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 Ben-Elazar et al.en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US
dc.source.volume17en_US
dc.source.journalPLoS Computational Biologyen_US
dc.source.issue2en_US
dc.identifier.doi10.1371/JOURNAL.PCBI.1008608
dc.identifier.cristin1917464
dc.source.articlenumbere1008608en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal